Cutting edge: Priming of NK cells by IL-18

J Immunol. 2008 Aug 1;181(3):1627-31. doi: 10.4049/jimmunol.181.3.1627.

Abstract

Recent evidence suggests that NK cells require priming to display full effector activity. In this study, we demonstrate that IL-18 contributed to this phenomenon. IL-18 signaling-deficient NK cells were found to be unable to secrete IFN-gamma in response to ex vivo stimulation with IL-12. This was not due to a costimulatory role of IL-18, because blocking IL-18 signaling during the ex vivo stimulation with IL-12 did not alter IFN-gamma production by wild-type NK cells. Rather, we demonstrate that IL-18 primes NK cells in vivo to produce IFN-gamma upon subsequent stimulation with IL-12. Importantly, IL-12-induced IFN-gamma transcription by NK cells was comparable in IL-18 signaling-deficient and -sufficient NK cells. This suggests that priming by IL-18 leads to an improved translation of IFN-gamma mRNA. These results reveal a novel type of cooperation between IL-12 and IL-18 that requires the sequential action of these cytokines.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cells, Cultured
  • Cross-Priming / immunology*
  • Interferon-gamma / biosynthesis
  • Interleukin-12 / pharmacology
  • Interleukin-18 / deficiency
  • Interleukin-18 / genetics
  • Interleukin-18 / immunology*
  • Interleukin-18 / metabolism*
  • Killer Cells, Natural / drug effects
  • Killer Cells, Natural / immunology*
  • Killer Cells, Natural / metabolism*
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Myeloid Differentiation Factor 88 / deficiency
  • Myeloid Differentiation Factor 88 / genetics
  • Myeloid Differentiation Factor 88 / metabolism
  • Signal Transduction / drug effects

Substances

  • Interleukin-18
  • Myd88 protein, mouse
  • Myeloid Differentiation Factor 88
  • Interleukin-12
  • Interferon-gamma